[go: up one dir, main page]

FI20030162L - Uusia yhdisteitä - Google Patents

Uusia yhdisteitä Download PDF

Info

Publication number
FI20030162L
FI20030162L FI20030162A FI20030162A FI20030162L FI 20030162 L FI20030162 L FI 20030162L FI 20030162 A FI20030162 A FI 20030162A FI 20030162 A FI20030162 A FI 20030162A FI 20030162 L FI20030162 L FI 20030162L
Authority
FI
Finland
Prior art keywords
new compounds
compounds
new
Prior art date
Application number
FI20030162A
Other languages
English (en)
Swedish (sv)
Other versions
FI20030162A7 (fi
Inventor
Victor Witold Jacewicz
Neal Ward
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27267578&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI20030162(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9502297.6A external-priority patent/GB9502297D0/en
Priority claimed from GBGB9503112.6A external-priority patent/GB9503112D0/en
Priority claimed from GBGB9509807.5A external-priority patent/GB9509807D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of FI20030162A7 publication Critical patent/FI20030162A7/fi
Publication of FI20030162L publication Critical patent/FI20030162L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI20030162A 1995-02-06 2003-02-03 Uusia yhdisteitä FI20030162L (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9502297.6A GB9502297D0 (en) 1995-02-06 1995-02-06 Novel compound
GBGB9503112.6A GB9503112D0 (en) 1995-02-17 1995-02-17 Novel compound
GBGB9509807.5A GB9509807D0 (en) 1995-05-15 1995-05-15 Novel compounds

Publications (2)

Publication Number Publication Date
FI20030162A7 FI20030162A7 (fi) 2003-02-03
FI20030162L true FI20030162L (fi) 2003-02-03

Family

ID=27267578

Family Applications (3)

Application Number Title Priority Date Filing Date
FI960519A FI111544B (fi) 1995-02-06 1996-02-05 Menetelmä sitoutunutta orgaanista liuotinta oleellisesti sisältämättömän paroksetiinihydrokloridin anhydraatin valmistamiseksi
FI20030162A FI20030162L (fi) 1995-02-06 2003-02-03 Uusia yhdisteitä
FI20030370A FI20030370A7 (fi) 1995-02-06 2003-03-12 Uusia yhdisteitä

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI960519A FI111544B (fi) 1995-02-06 1996-02-05 Menetelmä sitoutunutta orgaanista liuotinta oleellisesti sisältämättömän paroksetiinihydrokloridin anhydraatin valmistamiseksi

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI20030370A FI20030370A7 (fi) 1995-02-06 2003-03-12 Uusia yhdisteitä

Country Status (47)

Country Link
EP (3) EP1378508A1 (fi)
JP (2) JP2915338B2 (fi)
KR (1) KR100289885B1 (fi)
CN (3) CN1289496C (fi)
AR (2) AR001982A1 (fi)
AT (1) AT407528B (fi)
AU (2) AU701518C (fi)
BE (1) BE1009112A3 (fi)
BG (1) BG62967B1 (fi)
BR (1) BR9600534A (fi)
CA (4) CA2211522C (fi)
CH (3) CH689229A5 (fi)
CZ (1) CZ297171B6 (fi)
DE (3) DE19603797C2 (fi)
DK (2) DK11996A (fi)
DZ (1) DZ1989A1 (fi)
ES (1) ES2114471B1 (fi)
FI (3) FI111544B (fi)
FR (1) FR2730232B1 (fi)
GR (1) GR1002466B (fi)
HK (1) HK59397A (fi)
HU (1) HUP9600255A1 (fi)
IE (1) IE80500B1 (fi)
IL (1) IL117035A (fi)
IT (1) IT1289532B1 (fi)
LU (1) LU88711A1 (fi)
LV (1) LV11618B (fi)
MA (1) MA23802A1 (fi)
MC (1) MC2411A1 (fi)
MX (1) MX9600484A (fi)
MY (1) MY132529A (fi)
NL (1) NL1002248C2 (fi)
NO (3) NO301009B1 (fi)
NZ (1) NZ280943A (fi)
OA (1) OA10261A (fi)
PL (1) PL189247B1 (fi)
PT (1) PT101827B (fi)
RO (1) RO112426B1 (fi)
RU (1) RU2125052C1 (fi)
SE (1) SE521084C2 (fi)
SG (1) SG43787A1 (fi)
SI (2) SI9600036B (fi)
SK (1) SK283608B6 (fi)
TR (1) TR199600096A2 (fi)
TW (1) TW503238B (fi)
UA (1) UA49796C2 (fi)
WO (1) WO1996024595A1 (fi)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3882224B2 (ja) 1996-05-31 2007-02-14 旭硝子株式会社 パロキセチンの製造方法
EP0812827B1 (en) * 1996-06-13 2009-09-02 Sumitomo Chemical Company, Limited Piperidine derivative as intermediates for the preparation of paroxetine and process for their preparation
WO1998002556A2 (en) * 1996-07-15 1998-01-22 Smithkline Beecham Plc Screening for and use of an esterase for a stereospecific resolution
US6638948B1 (en) 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
US5672612A (en) * 1996-09-09 1997-09-30 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
CA2193939C (en) * 1996-12-24 2002-02-12 K.S. Keshava Murthy Useful form of anhydrous paroxetine hydrochloride
DK0994872T3 (da) 1997-06-10 2001-05-28 Synthon Bv 4-phenylpiperidin-forbindelser
PT903345E (pt) * 1997-08-08 2001-01-31 Aventis Pharma Gmbh Forma cristalina de n-(4-trifluorometilfenil)-5-metil-isoxazolo-4-carboxamida
GB9726907D0 (en) * 1997-12-19 1998-02-18 Smithkline Beecham Plc Novel compounds
JP2002506865A (ja) * 1998-03-16 2002-03-05 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー パロキセチンの結晶形
US6699882B2 (en) 1998-03-24 2004-03-02 Smithkline Beecham P.L.C. Paroxetine compositions
GB9806312D0 (en) * 1998-03-24 1998-05-20 Smithkline Beecham Plc Novel formulations
AU2003200534B2 (en) * 1998-03-24 2004-12-02 Smithkline Beecham Plc Paroxetine compositions
JP3796351B2 (ja) * 1998-04-13 2006-07-12 住友化学株式会社 パロキセチン塩酸塩無水和物の乾燥方法
GB9812941D0 (en) * 1998-06-16 1998-08-12 Smithkline Beecham Plc Method of treatment
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
ES2138937B1 (es) 1998-07-07 2000-10-01 Medichem Sa Polimorfo de maleato de paroxetina y formulaciones farmaceuticas que lo contienen.
DE69907467T2 (de) * 1998-08-07 2004-03-11 Smithkline Beecham Plc, Brentford Verfahren zur herstellung von einer nicht-kristallinen wasswerfreien form von paroxetin hydrochlorid
GB9824298D0 (en) * 1998-11-05 1998-12-30 Smithkline Beecham Plc Novel process
GB9826175D0 (en) * 1998-11-28 1999-01-20 Smithkline Beecham Plc Novel process
GB9826176D0 (en) * 1998-11-28 1999-01-20 Smithkline Beecham Plc Novel process
EP1135383B1 (en) * 1998-11-30 2003-12-03 SmithKline Beecham plc Mixed paroxetine propan-2-ol solvates
GB9826242D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
GB9826171D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel compounds
GB9826178D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
GB9826180D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
GB9828767D0 (en) * 1998-12-29 1999-02-17 Smithkline Beecham Plc Novel process
IT1308629B1 (it) * 1999-02-23 2002-01-09 Recordati Chem Pharm Processo per la produzione di paroxetina.
CA2367402C (en) * 1999-03-12 2010-11-23 Basf Aktiengesellschaft Stable pharmaceutical dosage form for paroxetine anhydrate
GB9914583D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel process
GB9914585D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel process
SE9902550D0 (sv) * 1999-07-02 1999-07-02 Astra Ab New crystalline forms
GB9919001D0 (en) * 1999-08-12 1999-10-13 Smithkline Beecham Plc Novel process
GB9923445D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
GB9923446D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
GB9923439D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
HU226912B1 (en) * 2000-04-07 2010-03-01 Richter Gedeon Nyrt New paroxetin salt and medicament containing it
AU2001286232A1 (en) * 2000-09-14 2002-03-26 Asahi Glass Company, Limited Process for producing paroxetine salt containing substantially no organic solvent
AU2002259114A1 (en) * 2002-02-22 2003-09-09 Teva Pharmaceutical Industries Ltd. Preparation of paroxetine involving novel intermediates
US7563930B2 (en) * 2005-11-22 2009-07-21 Teva Pharmaceutical Industries Ltd Crystal forms of Cinacalcet HCI and processes for their preparation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
DE3688827T2 (de) * 1985-10-25 1994-03-31 Beecham Group Plc Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel.
US5017585A (en) * 1986-11-03 1991-05-21 Novo Nordisk A/S Method of treating calcium overload
GB8626936D0 (en) * 1986-11-11 1986-12-10 Ferrosan As Treatment
DK716088D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Reduktion af piperidin-dion-derivater samt intermediat
DK715988D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Etherifikation og dealkylering af piperidin-derivater samt intermediater
JPH06502854A (ja) * 1990-11-24 1994-03-31 ビーチャム・グループ・パブリック・リミテッド・カンパニー 老年痴呆、過食症、片頭痛または食欲不振の治療用のパロキセチンの使用
US5258517A (en) * 1992-08-06 1993-11-02 Sepracor, Inc. Method of preparing optically pure precursors of paroxetine
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation

Also Published As

Publication number Publication date
FR2730232B1 (fr) 1997-08-01
EP0808314B1 (en) 2002-06-12
CA2168829A1 (en) 1996-08-07
TW503238B (en) 2002-09-21
CA2210023C (en) 1999-02-09
AR036856A2 (es) 2004-10-06
IE80500B1 (en) 1998-08-12
HUP9600255A1 (en) 1997-03-28
IL117035A (en) 2000-02-29
DE69631298D1 (de) 2004-02-12
AU4332896A (en) 1996-08-15
JPH08245620A (ja) 1996-09-24
ES2114471A1 (es) 1998-05-16
SK283608B6 (sk) 2003-10-07
AU701518B2 (en) 1999-01-28
ES2114471B1 (es) 1999-08-16
CA2211522C (en) 1999-12-07
CN1216055C (zh) 2005-08-24
EP0808314A1 (en) 1997-11-26
SG43787A1 (en) 1997-11-14
NO20015070L (no) 1996-08-07
NZ280943A (en) 1997-01-29
WO1996024595A1 (en) 1996-08-15
NO960472D0 (no) 1996-02-05
KR100289885B1 (ko) 2001-05-15
AR001982A1 (es) 1998-01-07
PL312646A1 (en) 1996-08-19
JPH11228571A (ja) 1999-08-24
SK14396A3 (en) 1996-11-06
CA2168829C (en) 1997-12-16
ITMI960203A1 (it) 1997-08-05
AU4786496A (en) 1996-08-27
FI960519L (fi) 1996-08-07
CA2210022C (en) 2005-09-13
CN1636993A (zh) 2005-07-13
SI21923B (sl) 2006-12-31
CN1310180A (zh) 2001-08-29
OA10261A (en) 1997-09-19
NL1002248A1 (nl) 1996-08-06
EP1136490B1 (en) 2004-01-07
JP2915338B2 (ja) 1999-07-05
DK11996A (da) 1996-08-07
DZ1989A1 (fr) 2002-10-15
RO112426B1 (ro) 1997-09-30
TR199600096A2 (tr) 1996-08-21
DK200100223A (fi) 2001-02-12
LU88711A1 (fr) 1996-08-23
FI20030370L (fi) 2003-03-12
CH688353A5 (de) 1997-08-15
NO301009B1 (no) 1997-09-01
CZ297171B6 (cs) 2006-09-13
SI21923A (sl) 2006-06-30
CN1090187C (zh) 2002-09-04
MX198371B (fi) 2000-08-29
MC2411A1 (fr) 1996-12-02
FI20030370A7 (fi) 2003-03-12
CA2211522A1 (en) 1996-08-07
MY132529A (en) 2007-10-31
CA2210022A1 (en) 1996-08-07
FI20030162A7 (fi) 2003-02-03
FR2730232A1 (fr) 1996-08-09
NO20015070D0 (no) 2001-10-18
RU2125052C1 (ru) 1999-01-20
SE9600406L (sv) 1996-08-07
DE19603797C2 (de) 1998-11-12
LV11618B (en) 1997-04-20
CN1289496C (zh) 2006-12-13
FI960519A0 (fi) 1996-02-05
SE9600406D0 (sv) 1996-02-05
NL1002248C2 (nl) 1996-09-11
AU701518C (en) 2006-12-07
NO960472L (no) 1996-08-07
KR960031409A (ko) 1996-09-17
BE1009112A3 (fr) 1996-11-05
NO311519B1 (no) 2001-12-03
CA2210023A1 (en) 1996-08-07
DE69621777D1 (de) 2002-07-18
BG100333A (bg) 1996-08-30
IT1289532B1 (it) 1998-10-15
CZ32096A3 (en) 1996-08-14
GR1002466B (el) 1996-11-06
SI9600036B (sl) 2006-12-31
HU9600255D0 (en) 1996-03-28
BG62967B1 (bg) 2000-12-29
AT407528B (de) 2001-04-25
PT101827B (pt) 1997-08-29
HK59397A (en) 1997-05-16
LV11618A (lv) 1996-12-20
PL189247B1 (pl) 2005-07-29
CH689229A5 (de) 1998-12-31
IL117035A0 (en) 1996-09-12
NO970939D0 (no) 1997-02-28
MX9600484A (es) 1997-01-31
CN1143643A (zh) 1997-02-26
EP1378508A1 (en) 2004-01-07
FI111544B (fi) 2003-08-15
BR9600534A (pt) 1997-05-13
ITMI960203A0 (fi) 1996-02-05
SI9600036A (en) 1996-10-31
DE19603797A1 (de) 1996-08-14
CH689804A5 (de) 1999-11-30
ATA21096A (de) 2000-08-15
NO301009B3 (fi) 2003-01-06
PT101827A (pt) 1996-09-30
NO970939L (no) 1996-08-07
DE69631298T2 (de) 2004-11-18
SE521084C2 (sv) 2003-09-30
UA49796C2 (uk) 2002-10-15
MA23802A1 (fr) 1996-10-01
DE69621777T2 (de) 2003-01-02
IE960104A1 (en) 1996-08-07
EP1136490A1 (en) 2001-09-26

Similar Documents

Publication Publication Date Title
BR9607097A (pt) Novos compostos
FI20030370L (fi) Uusia yhdisteitä
ID16345A (id) Senyawa-senyawa heterosiklik
DK1114817T3 (da) Substituerede benzylaminopiperidinforbindelser
DK0777671T3 (da) Spiro-azabicykliske forbindelser
FI971260A7 (fi) 1-asyyli-4-alifatyyliaminopiperidiiniyhdisteet
DE59609887D1 (de) Substituierte cyanophenyluracile
DE69608259D1 (de) Verbunddamenbinde
BR9600251A (pt) Composto
EE9800172A (et) Ühendid
NO974170D0 (no) Polyazacykloalkan-forbindelser
DE59610332D1 (de) Substituierte aminouracile
FI970151A0 (fi) Viruksenvastaisesti vaikuttavia difluoristatoniyhdisteitä
BR9601295A (pt) Composto
BR9609319A (pt) Carbonilaminofeniluracilas substituídas
BR9608890A (pt) N-metilenotiouréias substituídas
BR9611576A (pt) Composto
NO972257D0 (no) 18-nor-vitamin D-forbindelser
BR9603376A (pt) Tetrahidro-5-nitro-pirimidinas substituídas
DE59607732D1 (de) Substituierte benzylidencyanessigester
FI971971A7 (fi) Pyridatsinokinoliiniyhdisteitä
ID18956A (id) Senyawa-senyawa herbisida
DE59607958D1 (de) Substituierte phenyluracile
BR9610194A (pt) Aminouracilas substituídas
DE59600405D1 (de) Gehhilfe